Androgen Deprivation Therapy and the Risk of Coronary Heart Disease and Heart Failure in Patients with Prostate Cancer: A Nested Case-Control Study in UK Primary Care

Author： Martín-Merino Elisa  

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.34, Iss.11, 2011-11, pp. : 1061-1077

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Androgen deprivation therapy and the risk of death from prostate cancer among men with favorable or unfavorable intermediate-risk disease

By  

Cancer, Vol. 121, Iss. 16, 2015-08 ,pp. : 2713-2719

Blackwell Publishing

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer

By Singer Eric A   Golijanin Dragan J   Miyamoto Hiroshi   Messing Edward M  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 211-228

Informa Healthcare

Access to resources Recommend Favorite

Tibolone and Endometrial Cancer: A Cohort and Nested Case-Control Study in the UK

By de Vries Corinne S.  

Drug Safety, Vol. 28, Iss. 3, 2005-01 ,pp. : 241-249

Adis International

Access to resources Recommend Favorite

Current trends for the use of androgen deprivation therapy in conjunction with radiotherapy for patients with unfavorable intermediate-risk, high-risk, localized, and locally advanced prostate cancer

By Roach Mack  

Cancer, Vol. 120, Iss. 11, 2014-06 ,pp. : 1620-1629

Blackwell Publishing

Access to resources Recommend Favorite

Use of Statins and the Risk of Parkinson's Disease: A Retrospective Case-Control Study in the UK

By Becker Claudia  

Drug Safety, Vol. 31, Iss. 5, 2008-01 ,pp. : 399-407

Adis International

Access to resources Recommend Favorite